Business
Can the active ingredient in magic mushrooms help treat anxiety? Researchers want to know – The Age
New research sponsored by Monash University will explore if psilocybin and MDMA (“ecstasy”) can be used to treat anxiety and PTSD.
The chief principal investigator of the new trials, Monash research fellow Paul Liknaitzky, said current approaches to mental illness had failed many patients, with only about half responding to available treatments psychological or pharmacological and most relapsing when treatment stopped.
The largest of the studies will investigate whether a synthetic version of magic mushrooms can safely and effectively treat generalised anxiety disorder, a condition thought to affect about 6 per cent of Australians…
-
Noosa News15 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General23 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
Business21 hours agoCounter drone company surges past $1 billion valuation with new contract win
-
Business18 hours agoWhy are ASX 200 tech stocks like Xero shares taking a beating on Monday?